News
Biodesix
BDSX · NASDAQ
$23.87+$0.47 (+2.01%)TodayMarket closed ·
Prev close $23.40
Latest news
- Press releaseGlobe Newswire
Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
- Press releaseGlobe Newswire
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
- Press releaseGlobe Newswire
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
- Press releaseGlobe Newswire
Biodesix to Participate in Upcoming Investor Conferences
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
Biodesix Q1 2026 Earnings Call: Complete Transcript
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
Earnings Scheduled For May 4, 2026
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
- News
Biodesix Earnings Report: Q4 Overview
- News
Earnings Scheduled For February 26, 2026
- Press releaseGlobe Newswire
Biodesix to Participate in Upcoming Investor Conferences
- News
Market-Moving News for January 12th
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
Earnings Scheduled For November 3, 2025
- News
What's Next: Biodesix's Earnings Preview
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
- Press releaseGlobe Newswire
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
- Press releaseGlobe Newswire
Biodesix Announces One-for-Twenty Reverse Stock Split
- NewsRishabh Mishra
Stock Market Today: Dow Futures Slip, Nasdaq Rises As Trump Files Tariff Appeal—American Eagle, Salesforce, Lululemon In Focus (UPDATED)
- NewsAvi Kapoor
Why American Eagle Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics
- Press releaseGlobe Newswire
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
Biodesix to Participate in Upcoming Investor Conferences
- NewsAvi Kapoor
Why Toll Brothers Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsRishabh Mishra
US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says Expert
- Press releaseGlobe Newswire
Biodesix to Present at TD Cowen 45th Annual Health Care Conference
- Press releaseGlobe Newswire
Biodesix to Participate in Three Investor Conferences in November
- Press releaseBusiness Wire
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024
- Press releaseBusiness Wire
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
- NewsAvi Kapoor
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
- Press releaseBusiness Wire
Biodesix to Present at Two Investor Conferences in September
- Press releaseBusiness Wire
Biodesix Announces Second Quarter 2024 Results and Highlights
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.